Monoamine Oxidase Inhibitors in Depression: History and Mythology
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It was subsequently observed that iproniazid inhibited human monoamine oxidase, and the drug was therefore proposed to improve depressive symptoms through preventing the metabolism of serotonin, dopamine, and norepinephrine (Sandler, 1990).”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Sandler, 1990
Citations
Cites
Zeller, E. A., Barsky, J., Fouts, J. R., Kirchheimer, W. F., & Van Orden, L. S. (1952) · Experientia · doi:10.1007/bf02174413 · Cited by 264
In vivo Inhibition of Liver and Brain Monoamine Oxidase by 1-Isonicotinyl-2-Isopropyl Hydrazine.
Zeller, E. A., & Barsky, J. (1952) · Experimental Biology and Medicine · doi:10.3181/00379727-81-19910 · Cited by 253
A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer.
Loomer, H. P., SAUNDERS, J. C., & Kline, N. S. (1957) · PubMed · Cited by 205
MODIFICATIONS OF THE PHARMACOLOGY OF RESERPINE AND SEROTONIN BY IPRONIAZID
Chessin, M., Kramer, E. R., & Scott, C. C. (1957) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11898-3 · Cited by 112 · cited 4×
“to give a lecture and visited the department of Charles Scott who, with his colleagues, had shown that animals given iproniazid prior to reserpine became hyperalert and hyperactive (Chessin et al., 1956). Brodie, Pletscher and Shore (1956) had demonstrated a similar phenomenon. Kline thought that the combination might…”
BackgroundInfluentialTHE PSYCHIATRIC SIDE-EFFECTS OF IPRONIAZID
CRANE, G. E. (1956) · American Journal of Psychiatry · doi:10.1176/ajp.112.7.494 · Cited by 99
Synthetic tuberculostats. VII. Monoalkyl derivatives of isonicotinyhydrazine
FOX, H. H., & Gibas, J. T. (1953) · The Journal of Organic Chemistry · doi:10.1021/jo50014a014 · Cited by 52
FURTHER STUDIES ON IPRONIAZID PHOSPHATE: Isonicotinil-isopropylhydrazine phosphate Marsilid
CRANE, G. E. (1956) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-195609000-00014 · Cited by 46 · cited 4×
“Crane (1956b) noted euphoria after iproniazid administration but classed it with caffeine, amphetamine and cortisol, and never hinted at its possible exploitation in depressive patients.”
BackgroundInfluentialTHE EFFECT OF 1-ISONICOTYNL 2-ISOPROPYL HYDRAZIDE (IIH) ON THE BEHAVIOR OF LONG-TERM MENTAL PATIENTS
Kamman, G. R., FREEMAN, J. G., & Lucero, R. J. (1953) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-195311000-00002 · Cited by 40
III. The Effect of Isoniazid and of Iproniazid in Patients with Rheumatoid Arthritis
Scherbel, A. L. (1957) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.24.2.90 · Cited by 36 · cited 1×
“…to employ the euphoric side-effects therapeutically, these were only on debilitated patients, not on depressive illness per se; for example, Scherbel (1957) treated exhaustion, anxiety and depression in rheumatoid arthritics with iproniazid, while Crane (1956a) employed it in debilitated…”
BackgroundJa, S. (1953) · PubMed · Cited by 24
Research works printed but not linked: 16
- Bosworth D.M., 1955, Quart Bull Sea View Hosp, 16, 134
- Brodie B.B., 1956, J Pharmacol Exp Ther, 116, 9
- Chessin M., 1956, Fed Proc, 15, 409
- Kline N.S., 1958, J Clin Exp Psychopathol, 19, 72
- Kline N.S. (1970) Monoamine oxidase inhibitors: an unfinished picaresque tale In: Discoveries in biological psychiatry, eds F J Ayd, B Blackwell, Lippincott, Philadelphia , 194-204
- Lehmann H.E., Kline N.S. (1983) Clinical discoveries with antidepressant drugs In: Discoveries in pharmacology. Vol. 1: Psycho- and neuropharmacology, eds M J Parnham, J Bruinvels, Elsevier , Amsterdam, 209-221
- Loomer H.P., 1957, Congress Rec, 1382
- Loomer H.P., 1958, Psychiat Res Rep No. 8 Am Psychiat Assoc, 129
- Robitzek E.H., 1952, Quart Bull Sea View Hosp, 13, 27
- Saunders J.C., 1958, J Clin Exp Psychopath, 19, 84
- Saunders J.C., 1959, Ann NY Acad Sci, 80, 719
- Saunders J.C., Rochlin D.Z., Radinger N., Kline N.S. (1959) Iproniazid in depressed and regressed patients. In: Psychopharmacology frontiers, Little, Brown and Co , Boston, 177-194
- Smith J.A., 1953, Am Practitioner, 4, 519
- Zeller E.A., 1958, J Clin Exp Psychopathol, 19, 27
- Zeller E.A., 1952, J Pharmacol Exp Ther, 106, 427
- Zeller E.A., 1952, J Lab Clin Med, 40, 965
Cited by
Lopez-Munoz, F., & Alamo, C. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168001 · Cited by 476
“A decisive influence on this discovery were the large stocks of hydrazine discovered after World War II, having been used by the German army as fuel for their V2 rockets, and which were distributed to the chemical and pharmaceuticals industry at low cost [9].”
BackgroundBaldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Mechanisms of ketamine and its metabolites as antidepressants
Hess, E. M., Riggs, L. M., Michaelides, M., & Gould, T. D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114892 · Cited by 175
The discovery of antidepressants: A winding path
Pletscher, A. (1991) · Cellular and Molecular Life Sciences · doi:10.1007/bf02041242 · Cited by 99
The Marketing of5-Hydroxytryptamine: Depression or Anxiety?
Healy, D. (1991) · The British Journal of Psychiatry · doi:10.1192/bjp.158.6.737 · Cited by 60
Metadata
- Authors
- Sandler, M.
- Affiliations
- Queen Charlotte's and Chelsea Hospital (GB)
- Corresponding author
- Sandler, Merton
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 1990-05
- Volume
- 4
- Issue
- 3
- Pages
- 136-139
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2068793215
- Cited by
- 31
- References
- 13
- Citations by year
- 2026: 3 · 2023: 1 · 2022: 4 · 2021: 1 · 2020: 3 · 2018: 1 · 2016: 4 · 2014: 1 · 2012: 2
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Historical Psychiatry and Medical Practices
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Keywords
- monoamine oxidase inhibitors, depression, antidepressants
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Monoamine Oxidase Inhibitors in Depression: History and Mythology. https://app.cochat.ai/papers/10.1177/026988119000400307
- The paper
- Sandler, M. (1990). Monoamine Oxidase Inhibitors in Depression: History and Mythology. Journal of Psychopharmacology. https://doi.org/10.1177/026988119000400307
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.